ALG14

Across TCGA pan-cancer cohorts, ALG14 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ALG14’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where ALG14 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ALG14 is over-expressed in tumor, although a few such as PDAC and HNSC show the opposite, repressed pattern.

PDAC, HNSC, and LUAD are the cancer types where ALG14 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ALG14 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	Male	All	−1.365	<.001	6	view →
HNSC	All	II,III,IV	−0.250	.011	4	view →
LUAD	Male	All	+0.159	.001	3	view →
COAD	Female	II,III,IV	−0.216	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

ALG14–PDAC

Open the PDAC breakdown →